The obesity epidemic gathers growing media attention recently, as overweight and obesity’s prevalence keeps rising. This comes along with an increase in the intake of artificial sweeteners in food products. A causal relationship between the consumption of sweeteners and obesity is so far not clear in the medical literature. This paper describes the development of artificial sweeteners in a historical context. It collects epidemiological and experimental evidence that possibly relates the use of artificial sweeteners with weight gain. Finally, these effects are explained based on the neuroscience of food reward, the possible effects of glucose on the metabolism and the association between sweeteners and gut microbiota.
References
[1]
Ada Report (2004) Position of the American Dietetic Association: Use of Nutritive and Nonnutritive Sweeteners. Journal of the American Dietetic Association, 104, 255-275. https://doi.org/10.1016/j.jada.2003.12.001
[2]
Natividade, D.P., Denise de Andrade Rodrigues, C.G. and da Silva Vieira, V. (2011) XENOBIOTICS: Frequency of Inclusion in the Diet of Artificial Sweeteners Especially Aspartame, Sodium Cyclamate and Sodium Saccharin—Possible Adverse Effects. Revista Praxis, 3.
[3]
Stegink, L.D. (1987) The Aspartame Story: A Model for the Clinical Testing of a Food Additive. The American Journal of Clinical Nutrition, 46, 204-215.
https://doi.org/10.1093/ajcn/46.1.204
[4]
Sturtevant, F.M. (1985) Use of Aspartame in Pregnancy. International Journal of Fertility, 30, 85-87.
[5]
Torloni, M.R., et al. (2007) The Use of Sweeteners in Pregnancy: An Analysis of Products Available in Brazil. Revista Brasileira de Ginecologia e Obstetricia, 29, 267-275.
[6]
Butchko, H.H., et al. (2002) Aspartame: Review of Safety. Regulatory Toxicology and Pharmacology, 35, S1-S93. https://doi.org/10.1006/rtph.2002.1542
[7]
Centers for Disease Control (CDC) (1984) Evaluation of Consumer Complaints Related to Aspartame Use. Morbidity and Mortality Weekly Report, 33, 605-607.
[8]
Humphries, P., Pretorius, E. and Naude, H. (2008) Direct and Indirect Cellular Effects of Aspartame on the Brain. European Journal of Clinical Nutrition, 62, 451-462. https://doi.org/10.1038/sj.ejcn.1602866
[9]
Nofre, C. and Tinti, J.-M. (2000) Neotame: Discovery, Properties, Utility. Food Chemistry, 69, 245-257. https://doi.org/10.1016/S0308-8146(99)00254-X
[10]
Mayhew, D.A., Phil Comer, C. and Wayne Stargel, W. (2003) Food Consumption and Body Weight Changes with Neotame, a New Sweetener with Intense Taste: Differentiating Effects of Palatability from Toxicity in Dietary Safety Studies. Regulatory Toxicology and Pharmacology, 38, 124-143.
https://doi.org/10.1016/S0273-2300(03)00074-6
[11]
Abou-Donia, M.B., et al. (2008) Splenda Alters Gut Microflora and Increases Intestinal p-Glycoprotein and Cytochrome p-450 in Male Rats. Journal of Toxicology and Environmental Health A, 71, 1415-1429.
[12]
Von Rymon, L., Gert-Wolfhard and Hanger, L.Y. (2001) Alternative Sweeteners. Marcel Dekker, Inc., New York.
[13]
Kuhn, C., et al. (2004) Bitter Taste Receptors for Saccharin and Acesulfame K. Journal of Neuroscience, 24, 10260-10265.
https://doi.org/10.1523/JNEUROSCI.1225-04.2004
[14]
Zheng, Y. and Sarr, M.G. (2013) Effect of the Artificial Sweetener, Acesulfame Potassium, a Sweet Taste Receptor Agonist, on Glucose Uptake in Small Intestinal Cell Lines. Journal of Gastrointestinal Surgery, 17, 153-158.
[15]
Chang, J.-C., et al. (2005) Increase of Insulin Sensitivity by Stevioside in Fructose-Rich Chow-Fed Rats. Hormone and Metabolic Research, 37, 610-616.
[16]
Curi, R., et al. (1986) Effect of Stevia Rebaudiana on Glucose Tolerance in Normal Adult Humans. Brazilian Journal of Medical and Biological Research, 19, 771-774.
[17]
Anton, S.D., et al. (2010) Effects of Stevia, Aspartame, and Sucrose on Food Intake, Satiety, and Postprandial Glucose and Insulin Levels. Appetite, 55, 37-43.
[18]
Hsieh, M.-H., et al. (2003) Efficacy and Tolerability of Oral Stevioside in Patients with Mild Essential Hypertension: A Two-Year, Randomized, Placebo-Controlled Study. Clinical Therapeutics, 25, 2797-808.
[19]
Makinen, K.K. (2004) History, Safety, and Dental Properties of Xylitol.
[20]
Makinen, K.K. (2011) Sugar Alcohol Sweeteners as Alternatives to Sugar with Special Consideration of Xylitol. Medical Principles and Practice, 20, 303-320.
[21]
Avena, N.M., Rada, P. and Hoebel, B.G. (2008) Evidence for Sugar Addiction: Behavioral and Neurochemical Effects of Intermittent, Excessive Sugar Intake. Neuroscience & Biobehavioral Reviews, 32, 20-39.
[22]
Kobayakawa, T., et al. (1999) Spatio-Temporal Analysis of Cortical Activity Evoked by Gustatory Stimulation in Humans. Chemical Senses, 24, 201-209.
[23]
Ribeiro, G. and Osvaldo, S. (2013) Food Reward: Mechanisms Involved and Implications for Obesity. Portuguese Journal of Endocrinology, Diabetes and Metabolism, 8, 1-7.
[24]
Smeets, P.A.M., et al. (2005) Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Sweet Taste and Calories. The American Journal of Clinical Nutrition, 82, 1011-1016.
[25]
Cui, M., et al. (2006) The Heterodimeric Sweet Taste Receptor Has Multiple Potential Ligand Binding Sites. Current Pharmaceutical Design, 12, 4591-4600.
[26]
Haase, L., Cerf-Ducastel, B. and Murphy, C. (2009) Cortical Activation in Response to Pure Taste Stimuli during the Physiological States of Hunger and Satiety. Neuroimage, 44, 1008-1021.
[27]
Black, R.M., Leiter, L.A. and Harvey Anderson, G. (1993) Consuming Aspartame with and without Taste: Differential Effects on Appetite and Food Intake of Young Adult Males. Physiology & Behavior, 53, 459-466.
[28]
Blundell, J.E. and Hill, A.J. (1986) Paradoxical Effects of an Intense Sweetener (Aspartame) on Appetite. The Lancet, 1, 1092-1093.
https://doi.org/10.1016/S0140-6736(86)91352-8
[29]
Swithers, S.E. and Davidson, T.L. (2008) A Role for Sweet Taste: Calorie Predictive Relations in Energy Regulation by Rats. Behavioral Neuroscience, 122, 161-173.
[30]
Liem, D.G. and De Graaf, C. (2004) Sweet and Sour Preferences in Young Children and Adults: Role of Repeated Exposure. Physiology & Behavior, 83, 421-429.
[31]
Utzschneider, K.M., et al. (2016) Mechanisms Linking the Gut Microbiome and Glucose Metabolism. The Journal of Clinical Endocrinology & Metabolism, 101, 1445-1454. https://doi.org/10.1210/jc.2015-4251
[32]
Spencer, M., et al. (2016) Artificial Sweeteners: A Systematic Review and Primer for Gastroenterologists. Journal of Neurogastroenterology and Motility, 22, 168-180.
[33]
De Filippo, C., et al. (2010) Impact of Diet in Shaping Gut Microbiota Revealed by a Comparative Study in Children from Europe and Rural Africa. Proceedings of the National Academy of Sciences, 107, 14691-14696.
https://doi.org/10.1073/pnas.1005963107
[34]
Suez, J., et al. (2014) Artificial Sweeteners Induce Glucose Intolerance by Altering the Gut Microbiota. Nature, 514, 181-186. https://doi.org/10.1038/nature13793
[35]
Parséus, A., et al. (2017) Microbiota-Induced Obesity Requires Farnesoid X Receptor. Gut, 66, 429-437. https://doi.org/10.1136/gutjnl-2015-310283
[36]
Daly, K., Darby, A.C. and Shirazi-Beechey, S.P. (2016) Low Calorie Sweeteners and Gut Microbiota. Physiology & Behavior, 164, 494-500.
https://doi.org/10.1016/j.physbeh.2016.03.014
[37]
Winther, R., Aasbrenn, M. and Farup, P.G. (2017) Intake of Non-Nutritive Sweeteners Is Associated with an Unhealthy Lifestyle: A Cross-Sectional Study in Subjects with Morbid Obesity. BMC Obesity, 4, 41.
Lustig, R.H., Schmidt, L.A. and Brindis, C.D. (2012) Public Health: The Toxic Truth about Sugar. Nature, 482, 27-29. https://doi.org/10.1038/482027a
[40]
Fowler, S.P.G. (2016) Low-Calorie Sweetener Use and Energy Balance: Results from Experimental Studies in Animals, and Large-Scale Prospective Studies in Humans. Physiology & Behavior, 164, 517-523.
[41]
Yang, Q. (2010) Gain Weight by “Going Diet?” Artificial Sweeteners and the Neurobiology of Sugar Cravings: Neuroscience 2010. The Yale Journal of Biology and Medicine, 83, 101-108.
[42]
Bazzano, L.A., Hu, T., Reynolds, K., Yao, L., Bunol, C., Liu, Y., et al. (2014) Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial. Annals of Internal Medicine, 161, 309-318. https://doi.org/10.7326/M14-0180
